Trait Biosciences Unveils Tasteless, Odorless, Fully Water-soluble Cannabinoids
June 11th, 2019
LOS ALAMOS, N.M., June 10, 2019 /CNW/ — Trait Biosciences Inc. (“Trait” or the “Company“), North America’s leading research laboratory in hemp and cannabis innovations, has unveiled a suite of truly water-soluble cannabinoids that can be produced at commercial scale for the food, beverage and nutraceutical industries.
The breakthrough involved more than two years of research by more than 40 scientists and researchers at the company’s facility in Los Alamos, New Mexico. The water-soluble cannabinoids are now available in the form of a clear liquid and powder — either of which can be blended into water and are ideal for the development of premier quality cannabinoid-infused beverages and edible products.
Trait’s water-soluble cannabinoids can be easily and predictably absorbed into the bloodstream, as well as uniformly suspended and blended into a broad range of health and wellness, nutraceutical, and consumer products. (Photo here)
By transforming fat-based cannabinoids to water-soluble cannabinoids, Trait’s patented platform solves key challenges the cannabis industry has been facing. These benefits include:
- Eliminating the need to use nano-technologies to mix fat-based cannabinoids into products. Nano-particles have been linked to health concerns because they may penetrate the blood-brain barrier and have been known to accumulate in organs. See the health issues explained here.
- Improving onset time because water-soluble cannabinoids efficiently enter the bloodstream, much like the body metabolizes sugar or alcohol. Fat-based cannabinoids must be absorbed by the lower intestine, delaying onset times significantly.
- Provides superior stability, quality assurance and product shelf life. Eliminating the so-called salad-dressing effect, in which fat-based cannabinoids separate or glob together in beverage and foods, making it difficult to spread cannabinoids uniformly in products, essential to predict dosages.
- Delivering tasteless, odor-free and clear cannabis and hemp products. Trait’s breakthrough effectively eliminates the taste and odor issues associated with fat-based cannabinoids.
“This is the breakthrough our team has been working toward for almost two years,” said Trait’s Chief Science Officer Dr. Richard Sayre. “There is nothing like it in the industry. It’s a clear, tasteless and odor-free cannabis extract that can be easily added to consumer products, nutraceuticals and future medicines.”
“It’s essential that when people ingest a CBD or THC-based product that they know exactly how much they are taking, and what the onset time will be, not dissimilar to predicting the effect of alcohol when you have a glass of wine,” said Sayre. “Until now, nobody could promise that. Our Trait science team has now made this possible with this breakthrough in making water-soluble cannabinoids that are approximately one million times more water-soluble than cannabinoids now being used. This will revolutionize how cannabinoids are used in consumer products.”
Trait’s scientific team has been working on a water-soluble cannabinoid transformation process for more than two years under the direction of Sayre, an internationally recognized crop scientist who has been named by the prestigious scientific journal Nature as one of the five people who could change the world. In addition to Trait, Sayre is part of NASA’s team researching crops for a Mars mission and from 2005-2010 he served as director of the BioCassava Plus Program, funded by the Bill and Melinda Gates Foundation to add nutritional value to the cassava plant that is a staple of many African countries.
“A truly water-soluble cannabinoid is what the industry has been looking for,” said Trait CEO Peter McDonough. “Our technology will enable the industry to safely and reliably develop cannabinoid infused products that can be trusted and enjoyed within beverages, edibles and nutraceuticals. We are actively engaged in discussions with partners to produce premier quality, low-cost, water-soluble cannabinoids at commercial scale and believe our cannabinoids will be the catalyst for a broad new range of trusted, quality cannabinoid-infused products.”
About Trait Biosciences
With a team of internationally recognized scientists who are applying best-in-class technology and agricultural science, Trait Biosciences is an emerging biotechnology leader in the Hemp & Cannabis industry. Its consumer technology platforms provide breakthrough IP and science, which produce enhanced cannabinoids featuring predictable onset timing, superior bioavailability, extended stability and improved taste. Trait’s patent-pending technology includes a process for generating water-soluble cannabinoids that does not rely on emulsion or nanotechnology. The company’s agricultural technologies increase crop yields and plant safety, including ultrahigh yield “Super Producer” plants which dramatically increase a plant’s natural cannabinoid productivity, and its RNAi crop protection technology, which eliminates the need for pesticides or fungicides, providing higher quality safer CBD infused nutraceutical and pharmaceutical products.
Cautionary Statement on Forward-Looking Information
Certain information contained in this press release, including any information as to Trait Bioscience Inc.’s (the “Corporation”) strategy, projects, plans or future financial or operating performance, constitutes “forward-looking statements”. All statements, other than statements of historical fact, are forward-looking statements. The words “will”, “expect”, “continue”, “assess”, “anticipate” and similar expressions identify forward-looking statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions; including material estimates and assumptions that, while considered reasonable by the Corporation as at the date of this press release in light of each of management’s experience and perception of current conditions and expected developments, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements and undue reliance should not be placed on such statements and information.
Any forward-looking statements included in this document are made as of the date of this document and the Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Although management of the Corporation believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct.
SOURCE Trait Biosciences Inc.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.